AXDX Insider Trading Activity and SEC Form 4 Filings
AXDX insider trading summary
No open-market insider purchases or sales of Accelerate Diagnostics, Inc (AXDX) have been reported on SEC Form 4 in the past 12 months.
Latest AXDX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 4, 2025 | Jack Phillips | Chief Executive Officer | Sell | $16K (25,343 @ $0.65) |
| Apr 4, 2025 | Larry Michael Mertz | Chief Technology Officer | Sell | $990 (1,523 @ $0.65) |
| Apr 1, 2025 | David Patience | Chief Financial Officer | Sell | $5K (6,816 @ $0.71) |
| Feb 26, 2025 | David Patience | Chief Financial Officer | Sell | $583 (535 @ $1.09) |
| Feb 3, 2025 | Jack Phillips | Chief Executive Officer | Sell | $655 (485 @ $1.35) |
| Dec 3, 2024 | Jack W Schuler | Director | Sell | $314K (200,000 @ $1.57) |
| Dec 3, 2024 | John Patience | Director | Buy | $314K (200,000 @ $1.57) |
| May 20, 2024 | Larry Michael Mertz | Chief Technology Officer | Sell | $242 (275 @ $0.88) |
| May 20, 2024 | Larry Michael Mertz | Chief Technology Officer | Sell | $76 (86 @ $0.88) |
| Apr 17, 2024 | Jack Phillips | Chief Executive Officer | Sell | $21K (26,735 @ $0.78) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.